Operations and financials

EHA

Reservation Special Purpose Reserve

-

1,500

Result after donation Special Purpose Reserve

3,192

1,298

Liabilities

2022

2023

Reserves

25,914

28,711

Long Term Liabilities

1,008

1,483

Current Liabilities

3,932

5,642

Total Assets

30,854

35,836

Operational result

3,327

2,794

Financial income / (expenses)

(136)

4

Result

3,192

2,798

Expenses

Annual Congress

7.582

10,361

Research Mentoring

3,675

3,923

Education and Training

850

1,248

Direct Operations

186

1,868

Indirect Operations

5,446

3,092

European Projects

185

261

Total expenses

17,923

20,753

2022

2023

Income

21,251

23,546

Assets

2022

2023

Fixed assets

260

367

Current assets

1,957

4,136

Cash and Cash equivalents

28,637

31,333

Total Assets

30,854

35,836

EHA is a common good non-profit organization under Dutch law. It receives its funding through corporate partnerships with industry partners and through activity-based sponsorships for EHA’s programs.

Profits generated from its congress and other programs are invested in activities that serve the hematology community, according to the objectives and mission of EHA. EHA operates as a Board-led organization, with the Executive Board and its committee members contributing voluntarily for a specified term. The EHA Executive Office spearheads the implementation of the organization's strategy, supported by a team of highly experienced professionals.

Balance Sheet
as of December 31, 2023 (in €'000)

Statement of income and expenses in 2023 (in €'000)

Work plan and budget 2024

Drawing from EHA's strategic framework, valuable insights were gathered from the organization's Committees and Working Groups to shape the 2024 Work Plan and Budget.

Input was provided at two levels:

• EHA’s existing program portfolio and proposed strategic direction in 2024

• New EHA initiatives serving EHA’s overarching strategy

For both ongoing projects and new program initiatives, the scope and budget of these initiatives were developed and collected in a draft Work Plan and Budget 2024, which was approved by the Board.

 

Investing in the future

At the November meeting, the EHA Board also discussed its ambition to grow and expand activities in Knowledge, Congress & Meetings, and Engagement to ensure that EHA broadens its current benefits for members and non-members, and can fulfil and broaden its strategic goals. EHA’s financial position is solid, allowing the association to develop and implement valuable programs that contribute to achieving its strategic goals. New programs have been presented to the EHA Board to obtain approval for an additional investment plan for 2024 and beyond.

Notes to the financial statements

The financial statements are prepared in accordance with guideline RJ640 (non-profit organizations) of the Dutch Accounting Standards Board. The financial statements are prepared in Euros, the functional currency of the European Hematology Association.  Valuation of assets and liabilities and determination of the result takes place under the historical cost convention. Unless presented otherwise at the relevant principle for the specific balance sheet item, assets and liabilities are carried at nominal value. Income and expenses are accounted for on an accrual basis. Profits are only included when realized on the balance sheet date.

Losses originating before the end of the financial year are considered if they have become known before preparation of the financial statements. Revenues from goods are recognized upon delivery. The cost price of these goods is allocated to the same period. Revenues from services are recognized in proportion to the services rendered. The cost price of these services is allocated in the same period. Transactions in foreign currencies are recorded at the FX-rates of the dates of the transactions. At the end of the financial year the unsettled balances of foreign currency transactions are revalued at the year-end FX-rates.

Operations and financials

EHA

Reservation Special Purpose Reserve

-

1,500

Result after donation Special Purpose Reserve

3,192

1,298

Operational result

3,327

2,794

Financial income / (expenses)

(136)

4

Result

3,192

2,798

Expenses

Annual Congress

7.582

10,361

Research Mentoring

3,675

3,923

Education and Training

850

1,248

Direct Operations

186

1,868

Indirect Operations

5,446

3,092

European Projects

185

261

Total expenses

17,923

20,753

2022

2023

Income

21,251

23,546

Liabilities

2022

2023

Reserves

25,914

28,711

Long Term Liabilities

1,008

1,483

Current Liabilities

3,932

5,642

Total Assets

30,854

35,836

Assets

2022

2023

Fixed assets

260

367

Current assets

1,957

4,136

Cash and Cash equivalents

28,637

31,333

Total Assets

30,854

35,836

Losses originating before the end of the financial year are considered if they have become known before preparation of the financial statements. Revenues from goods are recognized upon delivery. The cost price of these goods is allocated to the same period. Revenues from services are recognized in proportion to the services rendered. The cost price of these services is allocated in the same period. Transactions in foreign currencies are recorded at the FX-rates of the dates of the transactions. At the end of the financial year the unsettled balances of foreign currency transactions are revalued at the year-end FX-rates.

The financial statements are prepared in accordance with guideline RJ640 (non-profit organizations) of the Dutch Accounting Standards Board. The financial statements are prepared in Euros, the functional currency of the European Hematology Association.  Valuation of assets and liabilities and determination of the result takes place under the historical cost convention. Unless presented otherwise at the relevant principle for the specific balance sheet item, assets and liabilities are carried at nominal value. Income and expenses are accounted for on an accrual basis. Profits are only included when realized on the balance sheet date.

Notes to the financial statements

At the November meeting, the EHA Board also discussed its ambition to grow and expand activities in Knowledge, Congress & Meetings, and Engagement to ensure that EHA broadens its current benefits for members and non-members, and can fulfil and broaden its strategic goals. EHA’s financial position is solid, allowing the association to develop and implement valuable programs that contribute to achieving its strategic goals. New programs have been presented to the EHA Board to obtain approval for an additional investment plan for 2024 and beyond.

Investing in the future

Input was provided at two levels:

  • EHA’s existing program portfolio and proposed strategic direction in 2024

  • New EHA program initiatives fitting within EHA’s overarching strategy

For ongoing projects as well as for new program initiatives, the scopes of these initiatives were developed, including the budgets, and collected in a draft Work Plan and Budget 2024, which was approved by the Board.

 

Drawing from EHA's strategic framework, valuable insights were gathered from the organization's Committees and Working Groups to shape the 2024 Work Plan and Budget.

Statement of income and expenses in 2023 (in €'000)

Balance Sheet
as of December 31, 2023 (in €'000)

Work plan and budget 2024

EHA is a common good non-profit organization under Dutch law. It receives its funding through corporate partnerships with industry partners and through activity-based sponsorships for EHA’s programs.

Profits generated from its congress and other programs are invested in activities that serve the hematology community, according to the objectives and mission of EHA. EHA operates as a Board-led organization, with the Executive Board and its committee members contributing voluntarily for a specified term. The EHA Executive Office spearheads the implementation of the organization's strategy, supported by a team of highly experienced professionals.